Katrina Ann Steiling, MD
Associate Professor, Medicine
Biography
Dr. Steiling is a Pulmonary/Critical Care physician with a longstanding interest in improving the ability to effectively detect, treat, and cure smoking-induced lung diseases such as lung cancer and chronic obstructive pulmonary disease (COPD). She completed her fellowship training in Pulmonary and Critical Care Medicine at Boston University Medical Center, and concurrently completed a Master of Science in Bioinformatics through the Boston University College of Engineering.
Dr. Steiling’s research career began with a focus on biomarker development for smoking-induced lung diseases such as lung cancer and chronic obstructive pulmonary disease (COPD). Using the airway field of injury hypothesis, which posits that cigarette smoking induces molecular changes throughout the respiratory tract, she studied alterations in the airway transcriptome that reflect the presence, susceptibility, and progression of smoking-induced lung diseases. Her laboratory used whole-genome expression profiling of the bronchial airway epithelium to describe the relationship between upper and lower airway gene expression, and leveraged this information to develop clinically relevant biomarkers of lung cancer and COPD, and other diseases that affect the lung.
Dr. Steiling transitioned her research focus and used the skills gained in large-scale genomics research to develop, implement, and study lung cancer screening and lung nodule evaluation programs. She implemented and oversees two large clinical programs related to lung health at Boston Medical Center, a tertiary urban safety-net hospital that provides most care to low-income, underserved and vulnerable patient populations. She developed, implemented, and directs the Lung Cancer Screening Program, which brings together multi-disciplinary expertise to provide evidence-based low-dose CT screening to high-risk patients. She also developed and directs the Lung Nodule Clinic, a sub-specialty clinic that provides patient-centered evidence-based care for incidental pulmonary nodules detected in high-risk settings.
Her current research is an outgrowth of her passion to mitigate health disparities through the development and implementation of lung cancer screening and lung nodule evaluation programs that serve diverse patient populations.
Dr. Steiling sees patients in the Lung Nodule Clinic, multi-disciplinary Thoracic Oncology Clinic and attends in the Medical Intensive Care Unit at Boston Medical Center.
Other Positions
- Member, BU-BMC Cancer Center, Boston University
- Member, Pulmonary Center, Boston University
- Member, Evans Center for Interdisciplinary Biomedical Research, Boston University
- Member, Bioinformatics Graduate Program, Boston University
- Member, Genome Science Institute, Boston University
Education
- Boston University School of Medicine, MD
- Boston University, MSc
- Boston College, BS
Classes Taught
- ENGBF831
Publications
- Published on 7/5/2024
Lee MM, Zuo Y, Steiling K, Mizgerd JP, Kalesan B, Walkey AJ. Clinical risk factors and blood protein biomarkers of 10-year pneumonia risk. PLoS One. 2024; 19(7):e0296139. PMID: 38968193.
Read at: PubMed - Published on 2/23/2024
Kearney L, Nguyen T, Steiling K. Disparities across the continuum of lung cancer care: a review of recent literature. Curr Opin Pulm Med. 2024 Jul 01; 30(4):359-367. PMID: 38411202.
Read at: PubMed - Published on 2/9/2024
Kearney LE, Jansen E, Kathuria H, Steiling K, Jones KC, Walkey A, Cordella N. Efficacy of Digital Outreach Strategies for Collecting Smoking Data: Pragmatic Randomized Trial. JMIR Form Res. 2024 Feb 09; 8:e50465. PMID: 38335012.
Read at: PubMed - Published on 1/15/2024
Steiling K, Kathuria H. Occupational Benzene Exposure: An Unrecognized Threat for Lung Cancer Development. Am J Respir Crit Care Med. 2024 Jan 15; 209(2):128-130. PMID: 38029296.
Read at: PubMed - Published on 1/1/2024
Steiling K. Evaluating the Impact of Race-Neutral Interpretation of Preoperative Pulmonary Function. Ann Am Thorac Soc. 2024 Jan; 21(1):32-34. PMID: 38156898.
Read at: PubMed - Published on 12/9/2023
Lee MM, Zuo Y, Steiling K, Mizgerd JP, Kalesan B, Walkey AJ. Clinical risk factors and blood protein biomarkers of 10-year pneumonia risk. medRxiv. 2023 Dec 09. PMID: 38105941.
Read at: PubMed - Published on 9/22/2023
Feeney ME, Steiling K. Successful management of suspected propofol dependence with phenobarbital in an adult patient with COVID-19. Am J Health Syst Pharm. 2023 Sep 22; 80(19):1309-1314. PMID: 37368792.
Read at: PubMed - Published on 3/15/2023
Steiling K, Kathuria H, Echieh CP, Ost DE, Rivera MP, Begnaud A, Celedón JC, Charlot M, Dietrick F, Duma N, Fong KM, Ford JG, Gould MK, Holguin F, Pérez-Stable EJ, Tanner NT, Thomson CC, Wiener RS, Wisnivesky J. Research Priorities for Interventions to Address Health Disparities in Lung Nodule Management: An Official American Thoracic Society Research Statement. Am J Respir Crit Care Med. 2023 Mar 15; 207(6):e31-e46. PMID: 36920066.
Read at: PubMed - Published on 11/28/2022
Liu A, Siddiqi N, Tapan U, Mak KS, Steiling KA, Suzuki K. Black Race Remains Associated with Lower Eligibility for Screening Using 2021 US Preventive Services Task Force Recommendations Among Lung Cancer Patients at an Urban Safety Net Hospital. J Racial Ethn Health Disparities. 2023 Dec; 10(6):2836-2843. PMID: 36441493.
Read at: PubMed - Published on 8/23/2022
Kathuria H, Gunawan A, Spring M, Aijaz S, Cobb V, Fitzgerald C, Wakeman C, Howard J, Clancy M, Foreman AG, Truong V, Wong C, Steiling K, Lasser KE, Bulekova K, Wiener RS. Hospitalization as an opportunity to engage underserved individuals in shared decision-making for lung cancer screening: results from two randomized pilot trials. Cancer Causes Control. 2022 Nov; 33(11):1373-1380. PMID: 35997854.
Read at: PubMed
View 40 more publications: View full profile at BUMC